Clinical Trials Logo

Citation(s)

  •   Akhondzadeh S, Shasavand E, Jamilian H, Shabestari O, Kamalipour A
    Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J Clin Pharm Ther. 2000 Apr;25(2):131-7.
  •   Dixon DA, Fenix LA, Kim DM, Raffa RB
    Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Ann Pharmacother. 1999 Apr;33(4):480-8. Review.
  •   Ferré S
    Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berl). 1997 Sep;133(2):107-20. Review.

Clinical Trial of Dipyridamole in Schizophrenia

Details for clinical trial NCT00349973